Plante Moran Financial Advisors’s Genomic Health, Inc. GHDX Stock Holding History

Plante Moran Financial Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-200	Closed	-$14K	–	955
2019 Q3	$14K	Hold	200	–	–	﹤0.01%	552
2019 Q2	$12K	Hold	200	–	–	﹤0.01%	548
2019 Q1	$14K	Hold	200	–	–	﹤0.01%	522
2018 Q4	$13K	Hold	200	–	–	﹤0.01%	478
2018 Q3	$14K	Hold	200	–	–	﹤0.01%	466
2018 Q2	$10K	Hold	200	–	–	0.01%	548
2018 Q1	$6K	Hold	200	–	–	﹤0.01%	702
2017 Q4	$7K	Hold	200	–	–	﹤0.01%	661
2017 Q3	$6K	Hold	200	–	–	﹤0.01%	641
2017 Q2	$7K	Hold	200	–	–	﹤0.01%	626
2017 Q1	$6K	Hold	200	–	–	﹤0.01%	689
2016 Q4	$6K	Hold	200	–	–	﹤0.01%	694
2016 Q3	$6K	Hold	200	–	–	﹤0.01%	675
2016 Q2	$5K	Hold	200	–	–	﹤0.01%	654
2016 Q1	$5K	Hold	200	–	–	﹤0.01%	599
2015 Q4	$7K	Hold	200	–	–	0.01%	661
2015 Q3	$4K	Buy	+200	New	+$5.15K	﹤0.01%	626

Plante Moran Financial Advisors's GHDX Position: Q4 2019 in Review

Plante Moran Financial Advisors sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 200 shares — an estimated $14K sold.

Plante Moran Financial Advisors first reported a position in GHDX in Q3 2015 and held it in 17 quarters. The position peaked at $14K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Plante Moran Financial Advisors reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Plante Moran Financial Advisors sold 200 Genomic Health, Inc. shares in Q4 2019, an estimated $14K.
Plante Moran Financial Advisors first reported a position in Genomic Health, Inc. in Q3 2015 and held it in 17 quarters.
Plante Moran Financial Advisors's Genomic Health, Inc. position peaked at $14K in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Plante Moran Financial Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.